Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Julie Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dana Aftab - $7.70M in EXEL purchases and sales in the last 12 months
- Patrick J. Haley - $7.60M in EXEL purchases and sales in the last 12 months
- Jack L. Wyszomierski - $4.58M in EXEL purchases and sales in the last 12 months
- Christopher J. Senner - $4.56M in EXEL purchases and sales in the last 12 months
- Stelios Papadopoulos - $4.36M in EXEL purchases and sales in the last 12 months
- Adrian R. Krainer - $3.90M in STOK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Julie Smith?
Julie Smith is a corporate insider of Stoke Therapeutics, Inc. (STOK). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Julie Smith last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 3 filings going back to 2026.
Has Julie Smith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($4.69M) across all tracked filings.
